Fcγ receptor biology and systemic lupus erythematosus

International Journal of Rheumatic Diseases

Volumn 12, Issue 4, 2009, Pages 293-298

  Jovanovic, Vojislav ^a   Dai, Xilei ^a   Lim, Yan Ting ^a   Kemeny, David M ^a   MacAry, Paul A ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Autoimmune disease; Biomarker; Fragment crystallizable receptor (FcR); Signaling; Systemic lupus erythematosus (SLE)

Indexed keywords

ALPHA INTERFERON; CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING AFFINITY; CROSS LINKING; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODY FORMATION; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOMODULATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RECEPTORS, IGG; SIGNAL TRANSDUCTION;

EID: 71149119191     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01426.x     Document Type: Review

References (60)

1. Dhodapkar KM, Kaufman JL, Ehlers M. Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci USA 2005; Feb 22, 102(8):2910-15.
2. Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005; Oct, 115(10):2914-23.
3. Parren PW, Warmerdam PA, Boeije LC. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992; Oct, 90(4):1537-46.
4. van de Winkel JG, Capel PJ. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; May, 14(5):215-21.
5. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; Jan, 8(1):34-47.
6. Strzelecka A, Kwiatkowska K, Sobota A. Tyrosine phosphorylation and Fcgamma receptor-mediated phagocytosis. FEBS Lett 1997; Jan 2, 400(1):11-14.
7. Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol 2007; Oct, 37(10):2912-22.
8. Stewart-Akers AM, Cunningham A, Wasko MC, Morel PA. Fc gamma R expression on NK cells influences disease severity in rheumatoid arthritis. Genes Immun 2004; Nov, 5(7):521-9.
9. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001, 19:275-90.
10. Gessner JE, Heiken H, Tamm A, Schmidt RE. The IgG Fc receptor family. Ann Hematol 1998; Jun, 76(6):231-48.
11. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991, 9:457-92.
12. Stockinger H. Interaction of GPI-anchored cell surface proteins and complement receptor type 3. Exp Clin Immunogenet 1997, 14(1):5-10.
13. Galon J, Gauchat JF, Mazieres N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol 1996; Aug 1, 157(3):1184-92.
14. Sanchez-Mejorada G, Rosales C. Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol 1998; May, 63(5):521-33.
15. Majeed M, Caveggion E, Lowell CA, Berton G. Role of Src kinases and Syk in Fcgamma receptor-mediated phagocytosis and phagosome-lysosome fusion. J Leukoc Biol 2001; Nov, 70(5):801-11.
16. Garcia-Garcia E, Rosales C. Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol 2002; Dec, 72(6):1092-108.
17. Hallal-Calleros C, Agramonte-Hevia J, Garay-Canales C. Syk and Lyn phosphorylation induced by FcgammaRI and FgammaRII crosslinking is determined by the differentiation state of U-937 monocytic cells. Immunol Lett 2005; Jul 15, 99(2):169-79.
18. Huang ZY, Hunter S, Kim MK. The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases. J Leukoc Biol 2004; Aug, 76(2):491-9.
19. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008; Apr 18, 320(5874):373-6.
20. Bewarder N, Weinrich V, Budde P. In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation. Mol Cell Biol 1996; Sep, 16(9):4735-43.
21. Crowley MT, Costello PS, Fitzer-Attas CJ. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J Exp Med 1997; Oct 6, 186(7):1027-39.
22. Kiefer F, Brumell J, Al-Alawi N. The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils. Mol Cell Biol 1998; Jul, 18(7):4209-20.
23. Ivan E, Colovai AI. Human Fc receptors: critical targets in the treatment of autoimmune diseases and transplant rejections. Hum Immunol 2006; Jul, 67(7):479-91.
24. Bolland S, Ravetch JV. Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol 1999, 72:149-77.
25. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 2002; Jun 17, 195(12):1653-9.
26. Tackenberg B, Jelcic I, Baerenwaldt A. Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci USA 2009; Mar 24, 106(12):4788-92.
27. Radstake TR, Franke B, Wenink MH. The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis. Arthritis Rheum 2006; Dec, 54(12):3828-37.
28. Daeron M, Latour S, Malbec O. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995; Nov, 3(5):635-46.
29. Nimmerjahn F, Ravetch JV. Fcgamma receptors: old friends and new family members. Immunity 2006; Jan, 24(1):19-28.
30. Cady CT, Rice JS, Ott VL, Cambier JC. Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors. Immunol Rev 2008; Aug, 224:44-57.
31. Fukuyama H, Nimmerjahn F, Ravetch JV. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 2005; Jan, 6(1):99-106.
32. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; Jul, 41(7):1241-50.
33. Coxon A, Cullere X, Knight S. Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity 2001; Jun, 14(6):693-704.
34. Tsuboi N, Asano K, Lauterbach M, Mayadas TN. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008; Jun, 28(6):833-46.
35. Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol 2006; Nov 15, 177(10):7287-95.
36. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol 2003; 15, 171(6):3296-302.
37. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 1991; Aug 15, 147(4):1338-43.
38. Parren PW, Warmerdam PA, Boeije LC, Capel PJ, van de Winkel JG, Aarden LA. Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3. J Immunol 1992; Feb 1, 148(3):695-701.
39. Wu J, Edberg JC, Redecha PB. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; Sep 1, 100(5):1059-70.
40. Lehrnbecher T, Foster CB, Zhu S. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 1999; Dec 15, 94(12):4220-32.
41. Tsokos GC. Systemic lupus erythematosus. A disease with a complex pathogenesis. Lancet 2001; Dec, 358(Suppl):S65.
42. Salmon JE, Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; Apr, 44(4):739-50.
43. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; Sep, 40(9):1725.
44. Castro J, Balada E, Ordi-Ros J, Vilardell-Tarres M. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 2008; May, 7(5):345-51.
45. Karassa FB, Trikalinos TA, Ioannidis JP. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 2002; Jun, 46(6):1563-71.
46. Harley JB, Alarcon-Riquelme ME, Criswell LA. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; Feb, 40(2):204-10.
47. Pan F, Tang X, Zhang K. Genetic susceptibility and haplotype analysis between Fcgamma receptor IIB and IIIA gene with systemic lupus erythematosus in Chinese population. Lupus 2008; Aug, 17(8):733-8.
48. Kyogoku C, Dijstelbloem HM, Tsuchiya N. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCγR2B to genetic susceptibility. Arthritis Rheum 2002; May, 46(5):1242-54.
49. Floto RA, Clatworthy MR, Heilbronn KR. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005; Oct, 11(10):1056-8.
50. Brownlie RJ, Lawlor KE, Niederer HA. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med 2008; Apr 14, 205(4):883-95.
51. Liu Y, Masuda E, Blank MC. Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes. J Leukoc Biol 2005; May, 77(5):767-76.
52. Rudge EU, Cutler AJ, Pritchard NR, Smith KG. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J Exp Med 2002; Apr 15, 195(8):1079-85.
53. Su K, Wu J, Edberg JC. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCγR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004; Jun 1, 172(11):7186-91.
54. Su K, Yang H, Li X. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol 2007; Mar 1, 178(5):3272-80.
55. Manz RA, Lohning M, Cassese G, Thiel A, Radbruch A. Survival of long-lived plasma cells is independent of antigen. Int Immunol 1998; Nov, 10(11):1703-11.
56. Radbruch A, Muehlinghaus G, Luger EO. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; Oct, 6(10):741-50.
57. Xiang Z, Cutler AJ, Brownlie RJ. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 2007; Apr, 8(4):419-29.
58. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996; Jan 25, 379(6563):346-9.
59. Hoyer BF, Moser K, Hauser AE. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004; Jun 7, 199(11):1577-84.
60. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005; Jun 2, 435(7042):590-7.